Aug 2 (Reuters) – UK drugmaker AstraZeneca has been exploring a deal to combine with U.S. rival Bristol Myers Squibb , the Financial Times reported on Sunday, citing people familiar with the matter.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Fritz downs Jodar to lift D.C. title
VIDEO SHOWS: ATP 500 WASHINGTON DC OPEN FINAL HIGHLIGHTS WITH TAYLOR FRITZ BEATING RAFAEL JODAR…
ADVISORY-Incorrect alerts on AH Realty Trust withdrawn
Alerts on AH Realty Trust's annual outlook and second-quarter results were incorrect and have been…
US House panel seeks briefing on OpenAI's AI agent security breach
WASHINGTON, Aug 3 (Reuters) - The U.S. House of Representatives' cybersecurity committee asked OpenAI CEO…
